Anti-Müllerian hormone (AMH) testing has become one of the more frequently discussed fertility assessments for women in their mid-thirties and beyond. For women thinking about their reproductive timeline — whether actively trying to conceive or simply curious about their fertility — AMH results can feel both illuminating and anxiety-inducing.
Understanding what AMH actually measures, what the numbers mean (and don’t mean), and how they fit into the broader picture of reproductive health after 35 can help you approach any test results with a clearer, calmer perspective. As always, individual circumstances vary widely, and a healthcare provider or reproductive endocrinologist is the best source for personalized interpretation.
What AMH Is and What It Measures
AMH is a hormone produced by the granulosa cells of small, developing follicles in the ovaries. Because AMH is released throughout much of the menstrual cycle (unlike some other hormones that fluctuate more dramatically with cycle phase), it has become a commonly used marker for ovarian reserve — an estimate of the remaining pool of eggs in the ovaries.
According to the American College of Obstetricians and Gynecologists (ACOG), AMH testing is one tool among several used to assess ovarian reserve, often alongside antral follicle count (AFC) via ultrasound and other hormone levels. It provides a snapshot of follicle quantity rather than a direct measure of egg quality — an important distinction that is often overlooked in discussions about AMH results.
AMH and Egg Quality
One of the most significant limitations of AMH testing is that it does not directly measure egg quality. Two women with the same AMH level may have considerably different experiences trying to conceive, because egg quality — which influences fertilization success and embryo development — is not captured by AMH. Egg quality is known to be affected by age, but it cannot currently be assessed with a simple blood test. This is why AMH results, while informative, should always be interpreted as one piece of a larger picture.
How AMH Levels Change With Age
AMH levels naturally decline with age as the ovarian reserve diminishes over time. Research published in reproductive medicine journals has documented a gradual but significant decline in average AMH levels across the reproductive years, with more pronounced changes typically occurring after the mid-thirties. However, there is considerable individual variation — some women in their late thirties and early forties have AMH levels comparable to women in their late twenties, while others may see earlier or steeper declines.
Reference ranges for AMH vary between laboratories, and what is considered “low,” “normal,” or “high” depends on the specific assay used and the clinical context. This is one reason why AMH results are most meaningful when discussed with a clinician who can contextualize them rather than interpreted from online charts alone.
AMH and Fertility Prediction
It is important to understand that AMH is not a reliable predictor of natural conception success for individual women. Research has found that AMH levels correlate with response to ovarian stimulation in IVF protocols, which is one of its most clinically validated uses. However, studies — including a notable analysis published in the JAMA — have found that low AMH in women with regular cycles is not strongly predictive of reduced ability to conceive naturally. If you are trying to conceive and want to understand what AMH testing means for your situation, consulting a reproductive endocrinologist is the most useful next step. You may also find context in our overview of fertility changes after 35.
When AMH Testing May Be Recommended
AMH testing is commonly included in fertility evaluations when a woman is experiencing difficulty conceiving, considering fertility preservation (such as egg freezing), or planning assisted reproductive treatments like IVF. Some clinicians also offer AMH as part of general fertility screening for women over 35 who are thinking about their reproductive future.
It is less commonly used as a standalone screening tool for women who are not actively considering pregnancy, partly because the clinical implications of an unexpectedly low AMH result in someone not currently trying to conceive can cause significant distress without providing clear actionable guidance. If you are considering AMH testing outside of a specific fertility context, discussing the implications with a healthcare provider beforehand can help set realistic expectations for what the results will — and won’t — tell you.
AMH and Fertility Preservation
For women considering egg freezing or embryo banking, AMH is routinely used to estimate how many eggs may be retrieved during an ovarian stimulation cycle. Lower AMH generally correlates with a lower expected egg yield from stimulation, though successful retrievals can occur across a range of AMH levels. A reproductive endocrinologist can help model expected outcomes based on AMH, AFC, age, and other factors specific to your situation. For broader context on hormonal changes in this life phase, our discussion of hormonal shifts in the approach to perimenopause may be useful background reading.
How to Prepare for AMH Testing
One advantage of AMH testing is that it can be done at any point in the menstrual cycle, unlike FSH and estradiol which are typically measured on cycle day 2-3. There is generally no specific preparation required. Results are usually available within a few days and should be shared with your healthcare provider for interpretation in the context of your full health history.
If you receive results that are lower than expected, it is worth remembering that AMH is one data point among many, and its clinical meaning depends heavily on context. Many women with low AMH conceive naturally or successfully with fertility treatment.
🔮 Related Product Guide
If you’re tracking your cycle, our guide to ovulation test kits for women over 35 compares the most-reviewed options — from basic LH strips to quantitative hormone monitors — with context on what may matter more when cycles are shorter or less predictable after 35.
Frequently Asked Questions
Does a low AMH mean I can’t get pregnant naturally?
Not necessarily. Research, including studies in JAMA, has found that low AMH in women with regular menstrual cycles is not strongly predictive of reduced natural conception ability. AMH is primarily useful for predicting response to ovarian stimulation in IVF. A reproductive endocrinologist can provide the most nuanced interpretation of your results in context.
Can I improve my AMH levels?
AMH reflects the size of your remaining follicle pool and is not currently considered modifiable through lifestyle changes or supplements in a clinically meaningful way. Research in this area is limited and ongoing. Be cautious of products or protocols claiming to “boost” AMH, and discuss any such options with your healthcare provider before pursuing them.
How often should AMH be tested?
There is no universal recommendation for how frequently AMH should be retested. In fertility treatment contexts, it may be assessed periodically as part of monitoring. For general screening purposes, the appropriate interval depends on individual circumstances and is best determined in consultation with a healthcare provider.
Is AMH testing covered by insurance?
Coverage varies by insurance plan and the clinical indication for testing. It is worth checking with your insurance provider and healthcare team about coverage before scheduling the test.
Key Takeaways
- AMH is a marker of ovarian reserve — the remaining follicle pool — but does not directly measure egg quality.
- AMH levels decline naturally with age, with considerable individual variation in the pace and degree of decline.
- Low AMH in women with regular cycles has not been found to be a strong predictor of reduced natural conception ability in research studies.
- AMH is most clinically validated in the context of predicting ovarian response to stimulation for IVF, not as a standalone fertility predictor.
- Results are most meaningful when interpreted by a reproductive endocrinologist in the context of your complete health picture and reproductive goals.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.